SB
AVDL
Samsara BioCapital’s Avadel Pharmaceuticals AVDL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.98M | Sell |
675,504
-292,023
| -30% | -$2.58M | 1.22% | 15 |
|
|
2025
Q1 | $7.58M | Hold |
967,527
| – | – | 1.35% | 13 |
|
|
2024
Q4 | $10.2M | Hold |
967,527
| – | – | 1.4% | 12 |
|
|
2024
Q3 | $12.7M | Hold |
967,527
| – | – | 2.44% | 10 |
|
|
2024
Q2 | $13.6M | Hold |
967,527
| – | – | 2.85% | 9 |
|
|
2024
Q1 | $16.3M | Hold |
967,527
| – | – | 2.53% | 10 |
|
|
2023
Q4 | $13.7M | Hold |
967,527
| – | – | 2.13% | 13 |
|
|
2023
Q3 | $9.97M | Hold |
967,527
| – | – | 3.05% | 10 |
|
|
2023
Q2 | $15.9M | Sell |
967,527
-441,882
| -31% | -$7.28M | 2.8% | 7 |
|
|
2023
Q1 | $12.9M | Buy |
1,409,409
+750,000
| +114% | +$6.87M | 2.67% | 10 |
|
|
2022
Q4 | $4.72M | Hold |
659,409
| – | – | 1.02% | 21 |
|
|
2022
Q3 | $3.3M | Hold |
659,409
| – | – | 0.77% | 28 |
|
|
2022
Q2 | $1.61M | Hold |
659,409
| – | – | 0.43% | 38 |
|
|
2022
Q1 | $4.5M | Hold |
659,409
| – | – | 1.13% | 22 |
|
|
2021
Q4 | $5.33M | Buy |
659,409
+110,159
| +20% | +$890K | 1.03% | 22 |
|
|
2021
Q3 | $5.38M | Hold |
549,250
| – | – | 0.84% | 25 |
|
|
2021
Q2 | $3.7M | Hold |
549,250
| – | – | 0.46% | 30 |
|
|
2021
Q1 | $4.97M | Buy |
549,250
+115,000
| +26% | +$1.04M | 0.92% | 24 |
|
|
2020
Q4 | $2.9K | Buy |
+434,250
| New | +$2.9K | 0.29% | 33 |
|